Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Healthy Life Centers (Norwegian, 'Frisklivssentralen') is a municipal service in Norway that aims to promote both physical and mental health, as well as to limit the development of non-communicable diseases. Previous research has shown that receiving follow-up from Healthy Life Centers has led to higher levels of daily physical activity, in addition to improved self-reported health and quality of life among the participants. However, there is a lack of studies that have examined what kind of physiological health effects can be expected from participating in the Healthy Life Center's follow-up.
In this study, responses to the 12-week physical activity program of the Healthy Life Center will be compared with the responses in a negative control group that does not receive such follow-up. Both the intervention group and the reference group (the negative control group) will carry out the same tests and measurements before and after the 12 week period. The tests will include measurements of anthropometric variables (body height, body weight and waist circumference), body composition, arterial stiffness, resting blood pressure and blood variables (blood glucose, long-term blood glucose, blood lipid profile and inflammation markers), in addition to physical tests of mobility, balance, maximum aerobic capacity (maximal oxygen consumption) and maximum muscle strength. Questionnaires related to adherence to the Healthy Life Center follow-up, socio-demographic variables, eating and drinking habits, activity level, perceived physical fitness, motivation for exercise, and health-related quality of life will also be included.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention group | Active Comparator | Participants in the intervention group will receive 12-week follow-up from the Healthy Life Center |
|
| Control group | No Intervention | Participants in the intervention group will not receive follow-up from the Healthy Life Center |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Physical activity | Other | The participants will receive the possibility to attend weekly endurance, resistance and yoga exercise sessions administered by the Healthy Life Center. They will also receive personalized follow-up from the Healthy Life Center, and have the possibility to exercise at the local gym. |
| Measure | Description | Time Frame |
|---|---|---|
| Maximal oxygen consumption (measured in mL/kg body mass/min) | Difference in change between the two study arms from before to after the 12-week intervention/control period | From before to after the 12-week intervention/control period |
| Measure | Description | Time Frame |
|---|---|---|
| Balance, measured using the "single leg stance test" (measured in seconds) | Difference in change between the two study arms from before to after the 12-week intervention/control period | From before to after the 12-week intervention/control period |
| Mobility, measured using the "sit-and-reach" and the "back stretch" test (measured in centimeters) |
| Measure | Description | Time Frame |
|---|---|---|
| Activity level | Difference in change between the two study arms from before to after the 12-week intervention/control period | From before to after the 12-week intervention/control period |
| Adherence to the 12-week intervention (measured as the number of sessions the participant attended divided by the number of sessions prescribed) |
Intervention group
Inclusion Criteria:
Exclusion Criteria:
Reference group
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Knut Sindre Mølmen, PhD | Contact | +47 61 28 85 53 | knut.sindre.molmen@inn.no |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000073296 | Noncommunicable Diseases |
| D009765 | Obesity |
| D007333 | Insulin Resistance |
| D009140 | Musculoskeletal Diseases |
| D001523 | Mental Disorders |
| D002318 | Cardiovascular Diseases |
| ID | Term |
|---|---|
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D050177 | Overweight |
Not provided
Not provided
| ID | Term |
|---|---|
| D015444 | Exercise |
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
Difference in change between the two study arms from before to after the 12-week intervention/control period |
| From before to after the 12-week intervention/control period |
| Fat mass (measured in kilograms) | Difference in change between the two study arms from before to after the 12-week intervention/control period | From before to after the 12-week intervention/control period |
| Lean mass (measured in kilograms) | Difference in change between the two study arms from before to after the 12-week intervention/control period | From before to after the 12-week intervention/control period |
| Bone mineral density ( measured in g/cm2) | Difference in change between the two study arms from before to after the 12-week intervention/control period | From before to after the 12-week intervention/control period |
| Visceral fat (measured in grams) | Difference in change between the two study arms from before to after the 12-week intervention/control period | From before to after the 12-week intervention/control period |
| Blood glucose levels (serum, fasted state) | Difference in change between the two study arms from before to after the 12-week intervention/control period | From before to after the 12-week intervention/control period |
| Cholesterol and total triglyceride levels (serum, fasted state) | Difference in change between the two study arms from before to after the 12-week intervention/control period | From before to after the 12-week intervention/control period |
| Resting blood pressure | Difference in change between the two study arms from before to after the 12-week intervention/control period | From before to after the 12-week intervention/control period |
| Systemic inflammation markers (levels of c-reactive protein, TNF-alpha, interleukin 6 and interleukin 8 in serum, fasted state) | Difference in change between the two study arms from before to after the 12-week intervention/control period | From before to after the 12-week intervention/control period |
| Arterial stiffness | Difference in change between the two study arms from before to after the 12-week intervention/control period | From before to after the 12-week intervention/control period |
| Health-related quality of life (measured using the SF-36 questionnaire; scores from 0-100, where a higher score means a better outcome) | Difference in change between the two study arms from before to after the 12-week intervention/control period | From before to after the 12-week intervention/control period |
| Body mass index | Difference in change between the two study arms from before to after the 12-week intervention/control period | From before to after the 12-week intervention/control period |
| Maximal muscle strength (measured in newtons produced during a leg press exercise) | Difference in change between the two study arms from before to after the 12-week intervention/control period | From before to after the 12-week intervention/control period |
| Maximal muscle power (measured in watts produced during a leg press exercise) | Difference in change between the two study arms from before to after the 12-week intervention/control period | From before to after the 12-week intervention/control period |
| Waist circumference | Difference in change between the two study arms from before to after the 12-week intervention/control period | From before to after the 12-week intervention/control period |
For the intervention group |
| During the 12-week intervention |
| Compliance to the 12-week intervention (measured as the number of sessions the participant conducted the session as prescribed divided by the number of total sessions) | For the intervention group | During the 12-week intervention |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
| D012816 | Signs and Symptoms |
| D006946 | Hyperinsulinism |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |